Open Access · CC BY 4.0
Irisin as a Novel Modulator of Bone Remodeling in Paget’s disease: Clinical Insights
AACE Endocrinology and Diabetes · 2026-10
DOI: 10.1016/j.aed.2026.08.036 ↗Kurz gefasst
Fachartikel in der Zeitschrift AACE Endocrinology and Diabetes, 2026-10. Verfasst von Ali B. Roomi und 2 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Roomi, A. B., Al-Kariti, W., & Metwally, A. A. (2026). Irisin as a Novel Modulator of Bone Remodeling in Paget’s disease: Clinical Insights. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.08.036
Vancouver
Roomi AB, Al-Kariti W, Metwally AA. Irisin as a Novel Modulator of Bone Remodeling in Paget’s disease: Clinical Insights. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.08.036
BibTeX
@article{Roomi2026,
author = {Roomi, Ali B. and Al-Kariti, Wurood and Metwally, Asmaa A.},
title = {Irisin as a Novel Modulator of Bone Remodeling in Paget’s disease: Clinical Insights},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
doi = {10.1016/j.aed.2026.08.036}
}
EUVIMED